Angel Investor
Siddhant Jayakumar has been an angel investor in the following startups:
Sable Bio secures £1.5 million funding to revolutionize drug target safety evaluation with their AI-enhanced platform, offering substantial cost and time savings in drug development, ultimately delivering safer drugs to patients faster.
Siddhant Jayakumar is an angel investor based in Cambridge, in the UK